JPH10195064A - Production of 5-amino-1,2,4-thiadiazoleacetic acid derivative (syn-isomer) - Google Patents

Production of 5-amino-1,2,4-thiadiazoleacetic acid derivative (syn-isomer)

Info

Publication number
JPH10195064A
JPH10195064A JP363497A JP363497A JPH10195064A JP H10195064 A JPH10195064 A JP H10195064A JP 363497 A JP363497 A JP 363497A JP 363497 A JP363497 A JP 363497A JP H10195064 A JPH10195064 A JP H10195064A
Authority
JP
Japan
Prior art keywords
isomer
amino
thiadiazol
methanol
syn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP363497A
Other languages
Japanese (ja)
Inventor
Takashi Inagaki
▲隆▼司 稲垣
Yasuyuki Kurita
泰行 栗田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KATAYAMA SEIYAKUSHIYO KK
Original Assignee
KATAYAMA SEIYAKUSHIYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KATAYAMA SEIYAKUSHIYO KK filed Critical KATAYAMA SEIYAKUSHIYO KK
Priority to JP363497A priority Critical patent/JPH10195064A/en
Publication of JPH10195064A publication Critical patent/JPH10195064A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain the subject compound advantageous for the production of an intermediate useful as an acylation agent for producing a 7- acylaminocephalosporin compound having excellent antibacterial activity by treating the anti-isomer of the compound with a strong acid. SOLUTION: The objective 2-substituted-hydroxyimino-2-(5-amino-1,2,4- thiadiazol-3-yl)acetic acid derivative (syn-isomer) of the formula I (R<1> is a lower alkyl, etc.; R<2> is a lower alkyloxy, etc.) can be produced by treating the compound of the formula II which is anti-isomer of the objective compound with a strong acid. The treatment is carried out in a solvent capable of dissolving the compound of the formula II such as water or methanol using hydrochloric acid, etc., as the strong acid. The amount of the acid is 0.01-10mol based on 1mol of the anti-isomer and the isomerization reaction temperature is 0-80 deg.C.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は5−アミノ−1,2,
4−チアジアゾール誘導体の製造方法に関する。本発明
の目的は、優れた抗菌活性を有する7−アシルアミノセ
ファロスポリン化合物を製造するためのアシル化剤とし
て有用な中間体である、下記の式(III)で示される2
−置換ヒドロキシイミノ−2−(5−アミノ−1,2,4
−チアジアゾール−3−イル)酢酸(シン異性体)(II
I)(R1は上記と同じ意味である)の製造に有利な2−
置換ヒドロキシイミノ−2−(5−アミノ−1,2,4−
チアジアゾール−3−イル)酢酸誘導体(I)(シン異
性体)の製造方法を提供することである。
[0001] The present invention relates to 5-amino-1,2,
The present invention relates to a method for producing a 4-thiadiazole derivative. An object of the present invention is to provide a compound represented by the following formula (III), which is an intermediate useful as an acylating agent for producing a 7-acylaminocephalosporin compound having excellent antibacterial activity.
-Substituted hydroxyimino-2- (5-amino-1,2,4
-Thiadiazol-3-yl) acetic acid (syn isomer) (II
I) 2- which is advantageous for the production of (R 1 has the same meaning as described above)
Substituted hydroxyimino-2- (5-amino-1,2,4-
An object of the present invention is to provide a method for producing a thiadiazol-3-yl) acetic acid derivative (I) (syn isomer).

【化3】 Embedded image

【0002】[0002]

【従来の技術および発明が解決しようとする課題】一般
にオキシム(ヒドロキシイミノ体)は塩酸により安定体
へ異性化が行われることが知られている。例えばp−ブ
ロモベンズアルデヒドオキシムのシン体は塩酸ガスによ
りアンチ体へ異性化することが知られている。
BACKGROUND OF THE INVENTION It is generally known that oximes (hydroxyimino forms) are isomerized to a stable form with hydrochloric acid. For example, it is known that a syn-form of p-bromobenzaldehyde oxime isomerized to an anti-form by hydrochloric acid gas.

【化4】 J.Org.Chem.,35,3546(1970)Embedded image J. Org. Chem., 35 , 3546 (1970).

【0003】しかしながら、これまで一般式(I)およ
び(II)で示されるような1,2,4−チアジアゾール環
を有する置換ヒドロキシイミノ体のアンチ体からシン体
への直接の異性化反応は報告されていない。1,2,4−
チアジアゾール環を有する置換ヒドロキシイミノ体のア
ンチ異性体からシン異性体に変換させる方法としては、
本発明者らはすでに、一般式(II)で示されるアンチ異
性体をギ酸と反応させてホルミル誘導体を経てシン異性
体に異性化する方法を見い出している(特願平第8−3
00121号参照)。
However, a direct isomerization reaction of a substituted hydroxyimino form having a 1,2,4-thiadiazole ring as shown by the general formulas (I) and (II) from an anti form to a syn form has been reported. It has not been. 1,2,4-
As a method of converting a substituted hydroxyimino form having a thiadiazole ring from an anti isomer to a syn isomer,
The present inventors have already found a method of reacting an anti-isomer represented by the general formula (II) with formic acid to isomerize to a syn-isomer via a formyl derivative (Japanese Patent Application No. 8-3).
No. 00121).

【0004】なお、本明細書において、下記の部分構造
を有するすべての化合物については式(Sn)で示され
る幾何構造を有する化合物を「シン異性体」と称し、式
(An)で示される構造を有する化合物は「アンチ異性
体」と称する。
[0004] In the present specification, all compounds having the following partial structure are referred to as compounds having a geometric structure represented by the formula (Sn) as "syn isomers", and are represented by the structure represented by the formula (An) Are referred to as “anti-isomers”.

【化5】 Embedded image

【0005】本発明者らは、一般式(II)で示される置
換ヒドロキシイミノ体(アンチ異性体)を直接一般式
(I)で示されるシン異性体に変換する方法について鋭
意検討した結果、強酸を適当量用いることによって、ア
ンチ異性体とシン異性体の溶解性の違いを利用しながら
効率よく異性化が進行することを見い出した。本発明は
上記のような知見に基づいて完成されたものである。
The present inventors have conducted intensive studies on a method of directly converting a substituted hydroxyimino compound (anti-isomer) represented by the general formula (II) into a syn isomer represented by the general formula (I), and as a result, It has been found that by using an appropriate amount of, isomerization proceeds efficiently while utilizing the difference in solubility between the anti isomer and the syn isomer. The present invention has been completed based on the above findings.

【0006】[0006]

【課題を解決するための手段】本発明の方法は、一般式
(I):
The process of the present invention comprises a compound of the general formula (I):

【化6】 (式中、R1は低級アルキルまたはフルオロメチル、R2
は低級アルキルオキシ、アミノ基またはヒドロキシル基
である)で示される2−置換ヒドロキシイミノ−2−
(5−アミノ−1,2,4−チアジアゾール−3−イル)
酢酸誘導体(シン異性体)(I)の製造方法であって、
一般式(II):
Embedded image (Wherein R 1 is lower alkyl or fluoromethyl, R 2
Is a lower alkyloxy, an amino group or a hydroxyl group).
(5-amino-1,2,4-thiadiazol-3-yl)
A method for producing an acetic acid derivative (syn isomer) (I),
General formula (II):

【化7】 (式中、R1およびR2は上記と同じ意味である)で示さ
れる2−置換ヒドロキシイミノ−2−(5−アミノ−1,
2,4−チアジアゾール−3−イル)酢酸誘導体(アン
チ異性体)(II)を強酸と処理させ、一般式(I)で示
されるシン異性体を製造することを特徴とする方法であ
る。
Embedded image (Wherein R 1 and R 2 have the same meanings as described above).
2,4-thiadiazol-3-yl) acetic acid derivative (anti isomer) (II) is treated with a strong acid to produce a syn isomer represented by the general formula (I).

【0007】すなわち、本発明の異性化反応は、下記の
反応式によって表すことができる。
That is, the isomerization reaction of the present invention can be represented by the following reaction formula.

【化8】 ここで、R1およびR2は上記と同じ意味である。Embedded image Here, R 1 and R 2 have the same meaning as described above.

【0008】上記反応は平衡反応であり、シン異性体へ
の異性化率がR2によって異なる。例えば、R2がアミノ
基の場合、過剰の酸を使用するとアンチ異性体が析出す
るが、少量の酸で加熱するとアンチ異性体はメタノール
に溶解し、シン異性体はメタノールに難溶なため、平衡
がシン異性体にずれ結晶として析出する。異性化率は約
90%である。
The above reaction is an equilibrium reaction, and the isomerization rate to a syn isomer differs depending on R 2 . For example, when R 2 is an amino group, an anti-isomer precipitates when an excess acid is used, but when heated with a small amount of acid, the anti-isomer dissolves in methanol, and the syn isomer is insoluble in methanol. The equilibrium shifts to the syn isomer and precipitates as crystals. The isomerization rate is about 90%.

【0009】[0009]

【発明の実施の形態】この明細書において、「低級アル
キル」とは、C1〜C5の飽和アルキル基をいい、好まし
くは、C1〜C3のアルキルであり、より好ましくは、C
1〜C2のアルキルである。具体的にはメチル、エチル、
n−プロピル、イソプロピル、n−ブチル、イソブチル、
t−ブチル、n−ペンチル、イソペンチルである。
BEST MODE FOR CARRYING OUT THE INVENTION In this specification, "lower alkyl" refers to a C 1 -C 5 saturated alkyl group, preferably C 1 -C 3 alkyl, more preferably C 1 -C 3 alkyl.
1 is an alkyl of ~C 2. Specifically, methyl, ethyl,
n-propyl, isopropyl, n-butyl, isobutyl,
t-butyl, n-pentyl and isopentyl.

【0010】R2が低級アルキルオキシの場合、異性化
率は85〜90%である。メタノールに対する溶解度が
シン異性体とアンチ異性体では異なるため(シン異性体
は難溶)、メタノール洗浄により高純度のシン異性体を
分離することができる。
When R 2 is lower alkyloxy, the isomerization ratio is 85-90%. Since the solubility in methanol differs between the syn isomer and the anti isomer (the syn isomer is hardly soluble), a high purity syn isomer can be separated by washing with methanol.

【0011】R2がヒドロキシル基の場合は、異性化率
60〜65%とやや悪い。従って工業的にはアミドまた
はエステル(一般式(II)でR2がそれぞれアミノ基、
低級アルキルオキシ基)でシン体に異性化したのち加水
分解して一般式(III)で示される2−置換ヒドロキシ
イミノ−2−(5−アミノ−1,2,4−チアジアゾール
−3−イル)酢酸(シン異性体)を合成するのが有利で
ある。
[0011] If R 2 is a hydroxyl group, a little bad and isomerization rate from 60 to 65%. Therefore, industrially, an amide or ester (where R 2 is an amino group,
A 2-substituted hydroxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) of the general formula (III) after isomerization to a syn-isomer with a lower alkyloxy group) followed by hydrolysis. It is advantageous to synthesize acetic acid (syn isomer).

【0012】一般式(II)で示される2−置換ヒドロキ
シイミノ−2−(5−アミノ−1,2,4−チアジアゾー
ル−3−イル)酢酸誘導体(アンチ異性体)は特願平8
−300121号に報告されているように、一般式(I
V):
The 2-substituted hydroxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetic acid derivative (anti-isomer) represented by the general formula (II) is disclosed in Japanese Patent Application No. 8-284,878.
As reported in US-300121, the general formula (I
V):

【化9】 (式中、R1およびR2は上記と同じ意味でであり、R3
はアルキルスルホニルまたはアリールスルホニルであ
る)で示される2−置換ヒドロキシイミノ−2−置換カ
ルボニルアセトアミド−o−置換オキシムをロダンカリ
ウムと反応させることによって得られる。
Embedded image (In the formula, R 1 and R 2 are the same meaning as above, R 3
Is an alkylsulfonyl or an arylsulfonyl) obtained by reacting a 2-substituted hydroxyimino-2-substituted carbonylacetamido-o-substituted oxime with potassium rhodan.

【0013】異性化反応に用いる溶媒は水、メタノー
ル、エタノール等またはこれらの混合物の一般式(II)
で示される化合物を溶解するものであればよく、経済
的、工業的には水、メタノールまたはこれらの混合物が
良好である。
The solvent used for the isomerization reaction is water, methanol, ethanol or the like, or a mixture thereof, represented by the general formula (II):
Any compound can be used as long as it dissolves the compound represented by the formula: water, methanol or a mixture thereof is economically and industrially favorable.

【0014】使用する酸は塩酸、硫酸、リン酸等の鉱
酸、p−トルエンスルホン酸、シュウ酸等の有機酸(ギ
酸を除く)、またはこれらの混合物であってもよい。異
性化効率が高く反応速度が大きい塩酸が好ましく、より
好ましくは塩酸ガスまたは濃塩酸が有利である。
The acid used may be a mineral acid such as hydrochloric acid, sulfuric acid or phosphoric acid, an organic acid such as p-toluenesulfonic acid or oxalic acid (excluding formic acid), or a mixture thereof. Hydrochloric acid having a high isomerization efficiency and a high reaction rate is preferable, and more preferably hydrochloric acid gas or concentrated hydrochloric acid is advantageous.

【0015】異性化反応におけるアンチ体1モルに対す
る酸の使用モル数は1:0.01〜10、好ましくは
1:0.02〜5、より好ましくは1:0.02〜4の範
囲である。より具体的には、酸の使用量はR2によって
異なる。R2が低級アルキルオキシ基の場合場合は、
1:0.25〜5、好ましくは、1:0.5〜2.5、よ
り好ましくは、1:0.75〜2.0である。R2がアミ
ノ基の場合1:0.01〜0.2、好ましくは、1:0.
02〜0.2、より好ましくは、1:0.02〜0.1で
ある。ただし、R1がCH2Fの場合はより大量に使用す
る方が好ましい。R2がヒドロキシル基の場合、1:2
〜10、好ましくは1:2〜5、より好ましくは1:2
〜3である。
The number of moles of the acid used per mole of the anti-isomer in the isomerization reaction is 1: 0.01 to 10, preferably 1: 0.02 to 5, and more preferably 1: 0.02 to 4. . More specifically, the amount of the acid used varies depending on R 2. When R 2 is a lower alkyloxy group,
The ratio is 1: 0.25 to 5, preferably 1: 0.5 to 2.5, and more preferably 1: 0.75 to 2.0. When R 2 is an amino group, it is 1: 0.01 to 0.2, preferably 1: 0.0.
02 to 0.2, more preferably 1: 0.02 to 0.1. However, when R 1 is CH 2 F, it is preferable to use a larger amount. 1: 2 when R 2 is a hydroxyl group
-10, preferably 1: 2-5, more preferably 1: 2
~ 3.

【0016】異性化反応の反応温度は0〜80℃、好ま
しくは10〜70℃、より好ましくは20〜60℃であ
る。より具体的には、R2が低級アルキルオキシ基の場
合、0〜50℃、好ましくは10〜40℃、より好まし
くは20〜35℃である。R2がアミノ基及びヒドロキ
シル基の場合、20〜80℃、好ましくは30〜70
℃、より好ましくは40〜60℃である。R1がCH2
である場合はより低温であることが好ましい。
[0016] The reaction temperature of the isomerization reaction is from 0 to 80 ° C, preferably from 10 to 70 ° C, more preferably from 20 to 60 ° C. More specifically, when R 2 is a lower alkyl group, 0 to 50 ° C., preferably from 10 to 40 ° C., more preferably 20 to 35 ° C.. When R 2 is an amino group or a hydroxyl group, the temperature is 20 to 80 ° C., preferably 30 to 70 ° C.
° C, more preferably 40 to 60 ° C. R 1 is CH 2 F
In this case, the temperature is preferably lower.

【0017】次に、製造例および実施例を示し、本発明
をさらに具体的に説明する。 製造例1 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)酢酸メチル(アンチ異性体)
[一般式(II)(式中、R1=Me、R2=OMe)]の
製造 (1)2−カルボキシ−2−メトキシイミノ−アセトアミ
ドオキシムの製造 2−シアノ−2−メトキシイミノ−アセトアミド24.
4g(0.19mol)、重炭酸ナトリウム32.2g(0.
38mol)を水に懸濁し、ヒドロキシルアミン塩酸塩1
3.3g(0.19mol)、水18.4gの溶液を80〜8
5℃で滴下した。同温度で3時間撹拌して反応後、反応
液を濃縮した。濃塩酸20gでpH2.0に調整したのち
冷却し生成した結晶を濾取した。得られた結晶をメタノ
ール20gで洗浄し、濾取、乾燥して27.1gの2−
カルボキシ−2−メトキシイミノ−アセトアミドオキシ
ムを得た。この結晶には14.8%の食塩を含む。実収
量23.1g、収率74.8%。
Next, the present invention will be described more specifically with reference to Production Examples and Examples. Production Example 1 Methyl 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetate (anti-isomer)
Production of [General Formula (II) (wherein, R 1 = Me, R 2 = OMe)] (1) Production of 2-carboxy-2-methoxyimino-acetamidooxime 2-cyano-2-methoxyimino-acetamido 24 .
4 g (0.19 mol), 32.2 g of sodium bicarbonate (0.19 mol)
38 mol) was suspended in water and hydroxylamine hydrochloride 1
A solution of 3.3 g (0.19 mol) and 18.4 g of water was added to 80-8.
It was added dropwise at 5 ° C. After stirring at the same temperature for 3 hours, the reaction solution was concentrated. After adjusting the pH to 2.0 with 20 g of concentrated hydrochloric acid, the mixture was cooled and the formed crystals were collected by filtration. The obtained crystals were washed with 20 g of methanol, collected by filtration, and dried to obtain 27.1 g of 2-
Carboxy-2-methoxyimino-acetamidooxime was obtained. The crystals contain 14.8% salt. Actual yield 23.1 g, yield 74.8%.

【0018】(2)o−トシル−2−メトキシカルボニル
−2−メトキシイミノ−アセトアミドオキシムの製造 上で得た2−カルボキシ−2−メトキシイミノ−アセト
アミドオキシム18.9g(実質16.1g(0.1mo
l))、メタノール31.5gの懸濁液に加熱還流下(63
〜67℃)に塩化チオニル12.5g(0.11mol)を
滴下した。滴下終了後2時間加熱還流し、減圧下で濃縮
した。残留液に酢酸エチル80g、重炭酸ナトリウム2
5g(0.3mol)、p−トルエンスルホニルクロライド2
1g(0.11mol)を添加した。内温5℃で水45gを
滴下し同温度で1夜撹拌反応した。90%酢酸6.7g
(1.0mol)を滴下して中和後、内温60℃以下で減圧
濃縮した。残留液に水45gを添加し、冷却して析出し
た結晶を濾取した。得られた結晶を70gのトルエンで
洗浄、濾取、乾燥して26.3g(収率79.9%)のo
−トシル−2−メトキシカルボニル−2−メトキシイミ
ノ−アセトアミドオキシムを得た。
(2) Preparation of o-tosyl-2-methoxycarbonyl-2-methoxyimino-acetamidooxime 18.9 g of 2-carboxy-2-methoxyimino-acetamidooxime obtained above (16.1 g (0.1%)). 1mo
l)), a suspension of methanol (31.5 g) was heated under reflux (63
(〜67 ° C.), 12.5 g (0.11 mol) of thionyl chloride was added dropwise. After completion of the dropwise addition, the mixture was heated under reflux for 2 hours and concentrated under reduced pressure. 80 g of ethyl acetate, sodium bicarbonate 2
5 g (0.3 mol), p-toluenesulfonyl chloride 2
1 g (0.11 mol) was added. At an internal temperature of 5 ° C., 45 g of water was added dropwise, and the mixture was stirred and reacted at the same temperature overnight. 6.7 g of 90% acetic acid
(1.0 mol) was added dropwise, and the mixture was neutralized. 45 g of water was added to the remaining liquid, and the precipitated crystals were collected by cooling and collected by filtration. The obtained crystals were washed with 70 g of toluene, collected by filtration, and dried to obtain 26.3 g (yield: 79.9%) of o.
-Tosyl-2-methoxycarbonyl-2-methoxyimino-acetamidooxime was obtained.

【0019】(3)2−メトキシイミノ−2−(5−アミノ
−1,2,4−チアジアゾール−3−イル)酢酸メチル
(アンチ異性体)の製造 ロダンカリウム16.2g(0.167mol)、メタノール
53gに上で得たo−トシル−2−メトキシカルボニル
−2−メトキシイミノ−アセトアミドオキシム18.3
g(0.056mol)を添加し、25〜30℃で24時間
反応した。不溶物を濾別し、不溶物をメタノール46g
で洗浄した。洗浄濾液は先の反応濾液と合わせメタノー
ルを減圧下に留去した。濃縮残渣に水28gを添加し冷
却して析出した結晶を濾取、乾燥し9.9g(収率82
%)の2−メトキシイミノ−2−(5−アミノ−1,2,
4−チアジアゾール−3−イル)酢酸メチル(アンチ異
性体)を得た。
(3) Preparation of methyl 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetate (anti-isomer) 16.2 g (0.167 mol) of potassium rhodan O-Tosyl-2-methoxycarbonyl-2-methoxyimino-acetamidooxime 18.3 obtained above in 53 g of methanol
g (0.056 mol) was added and reacted at 25-30 ° C for 24 hours. The insoluble material was filtered off, and the insoluble material was removed by 46 g of methanol.
And washed. The washing filtrate was combined with the previous reaction filtrate, and methanol was distilled off under reduced pressure. 28 g of water was added to the concentrated residue, and after cooling, the precipitated crystals were collected by filtration, dried and 9.9 g (yield 82).
%) Of 2-methoxyimino-2- (5-amino-1,2,2,
Methyl 4-thiadiazol-3-yl) acetate (anti isomer) was obtained.

【0020】製造例2 2−フルオロメトキシイミノ−2−(5−アミノ−1,
2,4−チアジアゾール−3−イル)酢酸メチル(アン
チ異性体)[一般式(II)(式中、R1=CH2F、R2
=OMe)]の製造 (1)2−カルボキシ−2−フルオロメトキシイミノ−ア
セトアミドオキシムの製造 エチル2−フルオロメトキシイミノ−シアノアセテート
46.6g(267.6mmol)に氷冷下、水酸化ナトリウ
ム12.9g(321.1mmol)を水268mlに溶解した
溶液を加え、3時間室温で撹拌した。氷冷下、ヒドロキ
シルアミン塩酸塩20.5g(294.4mmol)、ついで
炭酸カリウム16.7g(120.4mmol)を加えて室温
で一夜撹拌した。濃塩酸22.3ml(267.6mmol)を
加え(pH=2)、内温30℃で濃縮し結晶が析出したら
冷却し濾取、乾燥して21.3gの2−カルボキシ−2
−フルオロメトキシイミノ−アセトアミドオキシムを得
た。収率44.6%。
Production Example 2 2-Fluoromethoxyimino-2- (5-amino-1,
Methyl 2,4-thiadiazol-3-yl) acetate (anti-isomer) [wherein R 1 = CH 2 F, R 2
(OMe))] (1) Production of 2-carboxy-2-fluoromethoxyimino-acetamidooxime Sodium hydroxide 12.2 was added to 46.6 g (267.6 mmol) of ethyl 2-fluoromethoxyimino-cyanoacetate under ice-cooling. A solution of 9 g (321.1 mmol) dissolved in 268 ml of water was added, and the mixture was stirred at room temperature for 3 hours. Under ice cooling, 20.5 g (294.4 mmol) of hydroxylamine hydrochloride and 16.7 g (120.4 mmol) of potassium carbonate were added, and the mixture was stirred overnight at room temperature. 22.3 ml (267.6 mmol) of concentrated hydrochloric acid were added (pH = 2), and the mixture was concentrated at an internal temperature of 30 ° C., and when crystals precipitated, cooled, collected by filtration and dried, and dried to obtain 21.3 g of 2-carboxy-2.
-Fluoromethoxyimino-acetamidooxime was obtained. Yield 44.6%.

【0021】(2)o−トシル−2−メトキシカルボニル
−2−フルオロメトキシイミノ−アセトアミドオキシム
の製造 上で得られた2−カルボキシ−2−フルオロメトキシイ
ミノ−アセトアミドオキシム17.9g(100mmol)
をメタノール5mlに懸濁し、塩化チオニル13.1g
(110mmol)を添加し4時間還流した。メタノールを
濃縮し残渣に酢酸エチル50mlを添加し濃縮した。残渣
に酢酸エチル90mlを添加した懸濁液に重炭酸ナトリウ
ム25.2g(300mmol)、p−トルエンスルホニルク
ロライド19.1g(100mmol)を加え、水45mlを
添加して5℃以下で17時間撹拌して反応した。製造例
1と同様な手法で後処理してo−トシル−2−メトキシ
カルボニル−2−フルオロメトキシイミノ−アセトアミ
ドオキシム24.0g(収率69.1%)を得た。
(2) Preparation of o-tosyl-2-methoxycarbonyl-2-fluoromethoxyimino-acetamidooxime 17.9 g (100 mmol) of 2-carboxy-2-fluoromethoxyimino-acetamidooxime obtained above
Are suspended in 5 ml of methanol, and 13.1 g of thionyl chloride is suspended.
(110 mmol) and refluxed for 4 hours. The methanol was concentrated and the residue was concentrated by adding 50 ml of ethyl acetate. To a suspension obtained by adding 90 ml of ethyl acetate to the residue, 25.2 g (300 mmol) of sodium bicarbonate and 19.1 g (100 mmol) of p-toluenesulfonyl chloride were added, and 45 ml of water was added, followed by stirring at 5 ° C or lower for 17 hours. Reacted. Post-treatment was carried out in the same manner as in Production Example 1 to obtain 24.0 g (yield: 69.1%) of o-tosyl-2-methoxycarbonyl-2-fluoromethoxyimino-acetamidooxime.

【0022】(3)2−フルオロメトキシイミノ−2−(5
−アミノ−1,2,4−チアジアゾール−3−イル)酢酸
メチル(アンチ異性体)の製造 上で得られたo−トシル−2−メトキシカルボニル−2
−フルオロメトキシイミノ−アセトアミドオキシム2
2.6g(65mmol)を用いて、製造例と同様な手法に
より9.0g(収率59.2%)の2−フルオロメトキシ
イミノ−2−(5−アミノ−1,2,4−チアジアゾール
−3−イル)酢酸メチル(アンチ異性体)を得た。
(3) 2-fluoromethoxyimino-2- (5
Preparation of methyl-amino-1,2,4-thiadiazol-3-yl) acetate (anti-isomer) o-Tosyl-2-methoxycarbonyl-2 obtained above
-Fluoromethoxyimino-acetamidooxime 2
Using 2.6 g (65 mmol) and 9.0 g (yield 59.2%) of 2-fluoromethoxyimino-2- (5-amino-1,2,4-thiadiazole- 3- (yl) methyl acetate (anti isomer) was obtained.

【0023】製造例3 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)アセトアミド(アンチ異性
体)[一般式(II)(式中、R1=Me、R2=N
2)]の製造 (1)o−トシル−2−カルバモイル−2−メトキシイミ
ノアセトアミドオキシムの製造 2−シアノ−2−メトキシイミノアセトアミド12.7
g(0.1mol)、ヒドロキシルアミン塩酸塩7.3g
(0.105mol)、メタノール80mlの懸濁液に炭酸ナ
トリウム5.56g(0.0525mol)を添加し、17
時間室温撹拌した。氷冷し、炭酸ナトリウム6.89g
(0.065mol)、メタノール20mlを添加し、p−トル
エンスルホニルクロライド21.0g(0.11mol)を
氷冷下、少しずつ添加し、同温度で4時間撹拌した。水
100mlに分散冷却し析出した結晶を濾取、水洗し酢酸
エチル80mlで洗浄した。結晶を濾取、乾燥して20.
2g(収率64.3%)のo−トシル−2−カルバモイ
ル−2−メトキシイミノアセトアミドオキシムを得た。
Production Example 3 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetamide (anti-isomer) [General formula (II) wherein R 1 = Me , R 2 = N
H 2) production of] (1) o-tosyl-2-carbamoyl-2-methoxyiminomethyl manufacture of acetamide oxime 2-cyano-2-methoxyiminoacetamide 12.7
g (0.1 mol), 7.3 g of hydroxylamine hydrochloride
(0.105 mol) and 5.56 g (0.0525 mol) of sodium carbonate were added to a suspension of 80 ml of methanol.
Stirred at room temperature for hours. Cool on ice and add 6.89 g of sodium carbonate
(0.065 mol) and methanol (20 ml), p-toluenesulfonyl chloride (21.0 g, 0.11 mol) was added little by little under ice-cooling, and the mixture was stirred at the same temperature for 4 hours. The crystals were dispersed and cooled in 100 ml of water, and the precipitated crystals were collected by filtration, washed with water, and washed with 80 ml of ethyl acetate. The crystals are collected by filtration and dried.
2 g (yield 64.3%) of o-tosyl-2-carbamoyl-2-methoxyiminoacetamidooxime were obtained.

【0024】(2)2−メトキシイミノ−2−(5−アミノ
−1,2,4−チアジアゾール−3−イル)アセトアミド
(アンチ異性体)の製造 ロダンカリウム16.32g(168mmol)、メタノール
67mlに上で得られたo−トシル−2−カルバモイル−
2−メトキシイミノアセトアミドオキシム17.6g
(56mmol)を添加し、室温で24時間撹拌した。不溶
物を濾別し、不溶物をメタノール70mlで洗浄し、洗浄
濾液は反応濾液と合わせ、メタノールを減圧下で留去し
た。濃縮残渣をシリカゲルクロマトグラフィー(クロロ
ホルム7:メタノール1)で精製し、7.6g(収率6
7.5%)の2−メトキシイミノ−2−(5−アミノ−
1,2,4−チアジアゾール−3−イル)アセトアミド
(アンチ異性体)を得た。
(2) Preparation of 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetamide (anti isomer) 16.32 g (168 mmol) of potassium rhodane and 67 ml of methanol O-Tosyl-2-carbamoyl- obtained above
17.6 g of 2-methoxyiminoacetamidooxime
(56 mmol) and stirred at room temperature for 24 hours. The insoluble material was separated by filtration, the insoluble material was washed with 70 ml of methanol, the washed filtrate was combined with the reaction filtrate, and methanol was distilled off under reduced pressure. The concentrated residue was purified by silica gel chromatography (chloroform 7: methanol 1) to give 7.6 g (yield 6).
7.5%) of 2-methoxyimino-2- (5-amino-
(1,2,4-thiadiazol-3-yl) acetamide (anti isomer) was obtained.

【0025】製造例4 2−フルオロメトキシイミノ−2−(5−アミノ−1,
2,4−チアジアゾール−3−イル)アセトアミド(ア
ンチ異性体)[一般式(II)(式中、R1=CH2F、R
2=NH2)]の製造 2−シアノー2−フルオロメトキシイミノアセトアミド
2.9g(20mmol)を用いて製造例3と同様な手法に
より4.9g(収率73.8%)のo−トシル−2−カル
バモイル−2−フルオロメトキシイミノアセトアミドオ
キシムを得た。ロダンカリウム2.92g(30mmol)、
メタノール12mlに上で得たo−トシル−2−カルバモ
イル−2−フルオロメトキシイミノアセトアミドオキシ
ム3.32g(10mmol)を添加し、室温で24時間撹
拌した。製造例1と同様な手法で後処理して1.64g
(収率74.9%)の2−フルオロメトキシイミノ−2
−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)アセトアミド(アンチ異性体)を得た。
Production Example 4 2-Fluoromethoxyimino-2- (5-amino-1,
2,4-thiadiazol-3-yl) acetamide (anti-isomer) [general formula (II) (wherein R 1 = CH 2 F, R
2 = NH 2 )] 4.9 g (yield 73.8%) of o-tosyl- using 2.9 g (20 mmol) of 2-cyano 2-fluoromethoxyiminoacetamide in the same manner as in Preparation Example 3. 2-carbamoyl-2-fluoromethoxyiminoacetamido oxime was obtained. 2.92 g (30 mmol) of rhodane potassium,
To 12 ml of methanol was added 3.32 g (10 mmol) of o-tosyl-2-carbamoyl-2-fluoromethoxyiminoacetamidooxime obtained above, and the mixture was stirred at room temperature for 24 hours. Post-treated in the same manner as in Production Example 1 to give 1.64 g
(74.9% yield) of 2-fluoromethoxyimino-2
There was obtained-(5-amino-1,2,4-thiadiazol-3-yl) acetamide (anti-isomer).

【0026】[0026]

【実施例】下記の実施例において、アンチ体とシン体の
比率はHPLCにより測定した。 実施例1 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)酢酸メチル(シン異性体)
[一般式(I)(式中、R1=Me、R2=OMe)]の
製造 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)酢酸メチル(アンチ異性体)
61.4g(0.287mol)をメタノール430gに懸
濁し塩酸ガス10.5g(0.287mol)を加えると溶
解する。この反応液を室温下に24時間放置した。この
時のシン異性体:アンチ異性体の比率は約85:15で
あった。25%炭酸カリウム水溶液でpH7〜7.5に中
和したのち、減圧下にメタノールを留去(留出量280
g)し、水300gを添加して10℃に冷却、濾取、乾
燥して、2−メトキシイミノ−2−(5−アミノ−1,
2,4−チアジアゾール−3−イル)酢酸メチル(シン
異性体)42g(収率68.4%)を得た。このものの
シン異性体純度は99%以上であった。 mp;195〜197℃ IR(KBr)cm-1;3437,3130,1722,1
618,1531,1441,1406,1294,1
144,947 NMR(DMSO−d6)δ;3.72(3H,s),3.92
(3H,s),7.96(2H,bs)
EXAMPLES In the following examples, the ratio between the anti-form and the syn-form was measured by HPLC. Example 1 Methyl 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetate (syn isomer)
Production of [General Formula (I) (wherein, R 1 = Me, R 2 = OMe)] Methyl 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetate ( Anti isomer)
61.4 g (0.287 mol) is suspended in 430 g of methanol and dissolved by adding 10.5 g (0.287 mol) of hydrochloric acid gas. This reaction solution was left at room temperature for 24 hours. At this time, the ratio of syn isomer: anti isomer was about 85:15. After neutralization with a 25% aqueous solution of potassium carbonate to pH 7 to 7.5, methanol was distilled off under reduced pressure (distilled amount: 280).
g), 300 g of water was added, the mixture was cooled to 10 ° C, collected by filtration, and dried to give 2-methoxyimino-2- (5-amino-1,
42 g (yield 68.4%) of methyl 2,4-thiadiazol-3-yl) acetate (syn isomer) was obtained. Its syn isomer purity was 99% or more. mp; 195 to 197 ° C IR (KBr) cm -1 ; 3437, 3130, 1722, 1
618, 1531, 1441, 1406, 1294, 1
144,947 NMR (DMSO-d 6) δ; 3.72 (3H, s), 3.92
(3H, s), 7.96 (2H, bs)

【0027】濾液は減圧下にメタノールを留去し、10
℃に冷却、濾取、乾燥して、2−メトキシイミノ−2−
(5−アミノ−1,2,4−チアジアゾール−3−イル)
酢酸メチル(アンチ異性体)10.5gを得た。このも
のの純度は90%であった。
From the filtrate, methanol was distilled off under reduced pressure, and 10
C., filtered and dried to give 2-methoxyimino-2-
(5-amino-1,2,4-thiadiazol-3-yl)
10.5 g of methyl acetate (anti isomer) were obtained. Its purity was 90%.

【0028】実施例2 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)酢酸メチル(シン異性体)
[一般式(I)(式中、R1=Me、R2=OMe)]の
製造 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)酢酸メチル(アンチ異性体)
47.5g(0.22mol)をメタノール285gに懸濁
し、濃塩酸45.2g(0.44mol)を加える(溶解す
る)。この反応液を48時間、室温で放置した。この時
のシン異性体:アンチ異性体の比率は約80:20であ
った。20%炭酸カリウム水溶液でpH7〜7.5に中和
したのち、減圧下にメタノールを留去する(留出量14
5g)。水145gを添加、冷却(10℃)、濾取、乾燥
して31.8g(収率66.9%)の2−メトキシイミノ
−2−(5−アミノ−1,2,4−チアジアゾール−3−
イル)酢酸メチル(シン異性体)を得た。このシン異性
体の純度は99%以上であった。
Example 2 Methyl 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetate (syn isomer)
Production of [General Formula (I) (wherein, R 1 = Me, R 2 = OMe)] Methyl 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetate ( Anti isomer)
47.5 g (0.22 mol) of methanol are suspended in 285 g of methanol, and 45.2 g (0.44 mol) of concentrated hydrochloric acid is added (dissolved). The reaction was left at room temperature for 48 hours. At this time, the ratio of syn isomer: anti isomer was about 80:20. After neutralization with a 20% aqueous potassium carbonate solution to a pH of 7 to 7.5, methanol is distilled off under reduced pressure (distillation amount: 14
5g). 145 g of water was added, cooled (10 ° C.), collected by filtration and dried to obtain 31.8 g (yield 66.9%) of 2-methoxyimino-2- (5-amino-1,2,4-thiadiazole-3). −
Yl) Methyl acetate (syn isomer) was obtained. The purity of this syn isomer was 99% or more.

【0029】濾液は実施例1と同様な手法で後処理し1
2.4gの2−メトキシイミノ−2−(5−アミノ−1,
2,4−チアジアゾール−3−イル)酢酸メチル(シン
およびアンチ異性体の混合物)を得た。
The filtrate was post-treated in the same manner as in Example 1,
2.4 g of 2-methoxyimino-2- (5-amino-1,
Methyl 2,4-thiadiazol-3-yl) acetate (a mixture of syn and anti isomers) was obtained.

【0030】実施例3 2−フルオロメトキシイミノ−2−(5−アミノ−1,
2,4−チアジアゾール−3−イル)酢酸メチル(シン
異性体)[一般式(I)(式中、R1=CH2F、R2
OMe)]の製造 2−フルオロメトキシイミノ−2−(5−アミノ−1,
2,4−チアジアゾール−3−イル)酢酸メチル(アン
チ異性体)10g(42.7mmol)に4%塩酸−メタノ
ール溶液57g(塩酸62.9mmol)を加え、6時間撹
拌後室温で1夜放置した。反応終了後のシン異性体:ア
ンチ異性体の比率は90:10であった。30%炭酸カ
リウム水溶液でpH7に調整し、メタノールを減圧下に
留去(留出量52g)し、水50gを添加、冷却、濾
取、乾燥して7.58g(収率75.8%)の2−フルオ
ロメトキシイミノ−2−(5−アミノ−1,2,4−チア
ジアゾール−3−イル)酢酸メチル(シン異性体)を得
た。このもののシン異性体の純度は99%以上であっ
た。 mp;168〜170℃ IR(KBr)cm-1;3472,1732,1618,1
535,1441,1408,1288,1138,1
082,1055,997,980,930,849,
737,600 NMR(DMSO−d6)δ;3.83(3H,s),5.72
(2H,d,J=54Hz),8.10(2H,bs)
Example 3 2-Fluoromethoxyimino-2- (5-amino-1,
Methyl 2,4-thiadiazol-3-yl) acetate (syn isomer) [wherein R 1 = CH 2 F, R 2 =
OMe)] Production of 2-fluoromethoxyimino-2- (5-amino-1,
To 10 g (42.7 mmol) of methyl 2,4-thiadiazol-3-yl) acetate (42.7 mmol) was added 57 g of a 4% hydrochloric acid-methanol solution (62.9 mmol of hydrochloric acid), and the mixture was stirred for 6 hours and left at room temperature overnight. . After the reaction, the ratio of syn isomer: anti isomer was 90:10. The pH was adjusted to 7 with a 30% aqueous potassium carbonate solution, methanol was distilled off under reduced pressure (distillation amount: 52 g), water (50 g) was added, cooling, filtration, and drying were performed, and 7.58 g (75.8% yield) was obtained. Of 2-fluoromethoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetate (syn isomer). The purity of the syn isomer was 99% or more. mp; 168 to 170 ° C IR (KBr) cm -1 ; 3472, 1732, 1618, 1
535,1441,1408,1288,1138,1
082, 1055, 997, 980, 930, 849,
737,600 NMR (DMSO-d 6) δ; 3.83 (3H, s), 5.72
(2H, d, J = 54Hz), 8.10 (2H, bs)

【0031】実施例4 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)アセトアミド(シン異性体)
[一般式(I)(式中、R1=Me、R2=NH2)]の
製造 ロダンカリウム14.58g(150mmol)、メタノール
60mlに製造例3と同様にして得られた、o−トシル−
2−カルバモイル−2−メトキシイミノアセトアミドオ
キシム15.72g(50mmol)を添加し、室温で24
時間撹拌した。メタノールを濃縮し、水40mlを加え、
溶解し、活性炭0.5gを加え、濾過し、濾液を冷却
し、濃塩酸8.3ml(100mmol)を加えると結晶が析
出した。濾取し、2−メトキシイミノ−2−(5−アミ
ノ−1,2,4−チアジアゾール−3−イル)アセトアミ
ド(アンチ異性体)を得た(HPLC含量81.4%,
シン異性体7.9%)。この結晶を乾燥せずにメタノール
50ml、濃塩酸100μl(1.2mmol)を加え、内温約
55℃で30分間、加熱撹拌すると、一度溶解後、結晶
が析出する。冷却、濾取、洗浄(メタノール)、乾燥し
て、6.87g(収率68.3%)の2−メトキシイミノ
−2−(5−アミノ−1,2,4−チアジアゾール−3−
イル)アセトアミド(シン異性体)を得た。 HPLC含量98.6%(アンチ異性体1.2%) mp;245〜250℃(dec) IR(KBr)cm-1;3429,3252,3173,1
697,1605,1533,1458,1416,1
153,1043,874,820 NMR(DMSO−d6)δ;3.83(3H,s),7.44
(1H,bs),7.72(1H,bs),7.94(2H,bs)
Example 4 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetamide (syn isomer)
Preparation of [general formula (I) (wherein, R 1 = Me, R 2 = NH 2 )] o-tosyl obtained in the same manner as in Preparation Example 3 in 14.58 g (150 mmol) of potassium rhodanate and 60 ml of methanol −
15.72 g (50 mmol) of 2-carbamoyl-2-methoxyiminoacetamidooxime was added and the mixture was added at room temperature for 24 hours.
Stirred for hours. Concentrate the methanol, add 40 ml of water,
After dissolution, 0.5 g of activated carbon was added, the mixture was filtered, the filtrate was cooled, and 8.3 ml (100 mmol) of concentrated hydrochloric acid was added to precipitate crystals. The crystals were collected by filtration to give 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetamide (anti-isomer) (HPLC content: 81.4%,
Syn isomer 7.9%). Without drying the crystals, 50 ml of methanol and 100 μl (1.2 mmol) of concentrated hydrochloric acid are added, and the mixture is heated and stirred at an internal temperature of about 55 ° C. for 30 minutes. After cooling, filtration, washing (methanol) and drying, 6.87 g (yield 68.3%) of 2-methoxyimino-2- (5-amino-1,2,4-thiadiazole-3-) was obtained.
Yl) acetamide (syn isomer) was obtained. HPLC content 98.6% (anti-isomer 1.2%) mp; 245-250 ° C (dec) IR (KBr) cm -1 ; 3429,3252,3173,1
697,1605,1533,1458,1416,1
153,1043,874,820 NMR (DMSO-d 6) δ; 3.83 (3H, s), 7.44
(1H, bs), 7.72 (1H, bs), 7.94 (2H, bs)

【0032】実施例5 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)アセトアミド(シン異性体)
[一般式(I)(式中、R1=Me、R2=NH2)]の
製造 製造例3で得た2−メトキシイミノ−2−(5−アミノ
−1,2,4−チアジアゾール−3−イル)アセトアミド
(アンチ異性体)1.0g(5.0mmol)にメタノール6
ml、1N塩酸500μl(0.5mmol)を加え、浴温50
℃で7時間撹拌した。途中、加熱1時間後にシン異性体
の種晶を20mg添加した。冷却、濾取、乾燥して、76
5mg(収率74.5%)の2−メトキシイミノ−2−(5
−アミノ−1,2,4−チアジアゾール−3−イル)アセ
トアミド(シン異性体)を得た。HPLC含量99.4%
(アンチ異性体0.28%)
Example 5 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetamide (syn isomer)
Production of [General Formula (I) (wherein, R 1 = Me, R 2 = NH 2 )] 2-methoxyimino-2- (5-amino-1,2,4-thiadiazole) obtained in Production Example 3 3-yl) acetamide (anti-isomer) 1.0 g (5.0 mmol) in methanol 6
ml, 1N hydrochloric acid (500 μl, 0.5 mmol), and a bath temperature of 50 mL.
Stirred at C for 7 hours. On the way, after heating for 1 hour, 20 mg of a seed crystal of a syn isomer was added. Cool, filter, dry and dry
5 mg (74.5% yield) of 2-methoxyimino-2- (5
-Amino-1,2,4-thiadiazol-3-yl) acetamide (syn isomer) was obtained. HPLC content 99.4%
(0.28% anti-isomer)

【0033】実施例6 2−フルオロメトキシイミノ−2−(5−アミノ−1,
2,4−チアジアゾール−3−イル)アセトアミド(シ
ン異性体)[一般式(I)(式中、R1=CH2F、R2
=NH2)]の製造 製造例4で得た2−フルオロメトキシイミノ−2−(5
−アミノ−1,2,4−チアジアゾール−3−イル)アセ
トアミド(アンチ異性体)2.19g(10mmol)をメ
タノール40mlに溶解し、4%塩化水素メタノール溶液
13.7g(15mmol)を加えて室温で48時間、撹拌
した(シン異性体87%,アンチ異性体13%)。冷却
し、30%炭酸カリウム水溶液でpH≒7に調整し、メ
タノールを濃縮し水10mlで分散し、冷却、濾取した。
さらにメタノール8mlで洗浄、濾取、乾燥し、2−フル
オロメトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)アセトアミド(シン異性体)
1.46g(67.0%)を得た。 IR(KBr)cm-1;3412,3186,1701,1
622,1535,1420,1150,1076,1
053,1003,955,872,819 NMR(DMSO−d6)δ;5.72(2H,d,J=55H
z),7.63(1H,bs),7.93(1H,bs),8.04(2
H,bs)
Example 6 2-fluoromethoxyimino-2- (5-amino-1,
2,4-thiadiazol-3-yl) acetamide (syn isomer) [wherein R 1 CHCH 2 F, R 2
= NH 2 )] 2-fluoromethoxyimino-2- (5) obtained in Production Example 4
Dissolve 2.19 g (10 mmol) of -amino-1,2,4-thiadiazol-3-yl) acetamide (anti isomer) in 40 ml of methanol, add 13.7 g (15 mmol) of a 4% methanol solution of hydrogen chloride, and add room temperature. For 48 hours (87% syn isomer, 13% anti isomer). After cooling, the pH was adjusted to about 7 with a 30% aqueous potassium carbonate solution, the methanol was concentrated, dispersed with 10 ml of water, cooled and filtered.
Further, it was washed with 8 ml of methanol, collected by filtration, dried and dried to give 2-fluoromethoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetamide (syn isomer).
1.46 g (67.0%) were obtained. IR (KBr) cm -1 ; 3412,3186,1701,1
622, 1535, 1420, 1150, 1076, 1
053, 1003, 955, 872, 819 NMR (DMSO-d 6 ) δ; 5.72 (2H, d, J = 55H)
z), 7.63 (1H, bs), 7.93 (1H, bs), 8.04 (2
H, bs)

【0034】実施例7 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)酢酸(シン異性体)[一般式
(I)(式中、R1=CH3、R2=OH)]の製造 2−メトキシイミノ−2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)酢酸(アンチ異性体)10.
1g(0.05mol)を水54g、メタノール20gに加
え、加熱溶解後、濃塩酸16g(0.15mol)を加えて
45℃で12時間加熱した。この時のシン異性体:アン
チ異性体の比率は約65:45であった。冷却、濾取、
乾燥後、5.0g(収率49.5%)の2−メトキシイミ
ノ−2−(5−アミノ−1,2,4−チアジアゾール−3
−イル)酢酸(シン異性体)を得た。 HPLC含量 85.0%(アンチ異性体10.0%)
Example 7 2-methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetic acid (syn isomer) [General formula (I) wherein R 1 = CH 3, R 2 = OH)] Using 2- methoxyimino-2- (5-amino-1,2,4-thiadiazol-3-yl) acetic acid (anti-isomer) 10.
1 g (0.05 mol) was added to 54 g of water and 20 g of methanol. After heating and dissolving, 16 g (0.15 mol) of concentrated hydrochloric acid was added, and the mixture was heated at 45 ° C. for 12 hours. At this time, the ratio of syn isomer: anti isomer was about 65:45. Cooling, filtration,
After drying, 5.0 g (49.5% yield) of 2-methoxyimino-2- (5-amino-1,2,4-thiadiazole-3).
-Yl) acetic acid (syn isomer) was obtained. HPLC content 85.0% (anti-isomer 10.0%)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 一般式(I): 【化1】 (式中、R1は低級アルキルまたはフルオロメチル、R2
は低級アルキルオキシ、アミノ基またはヒドロキシル基
である)で示される2−置換ヒドロキシイミノ−2−
(5−アミノ−1,2,4−チアジアゾール−3−イル)
酢酸誘導体(シン異性体)(I)の製造方法であって、
一般式(II): 【化2】 (式中、R1およびR2は上記と同じ意味である)で示さ
れる2−置換ヒドロキシイミノ−2−(5−アミノ−1,
2,4−チアジアゾール−3−イル)酢酸誘導体(アン
チ異性体)(II)を強酸と処理させることを特徴とする
方法。
1. A compound of the general formula (I): (Wherein R 1 is lower alkyl or fluoromethyl, R 2
Is a lower alkyloxy, an amino group or a hydroxyl group).
(5-amino-1,2,4-thiadiazol-3-yl)
A method for producing an acetic acid derivative (syn isomer) (I),
General formula (II): (Wherein R 1 and R 2 have the same meanings as described above).
A method characterized in that 2,4-thiadiazol-3-yl) acetic acid derivative (anti isomer) (II) is treated with a strong acid.
JP363497A 1997-01-13 1997-01-13 Production of 5-amino-1,2,4-thiadiazoleacetic acid derivative (syn-isomer) Pending JPH10195064A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP363497A JPH10195064A (en) 1997-01-13 1997-01-13 Production of 5-amino-1,2,4-thiadiazoleacetic acid derivative (syn-isomer)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP363497A JPH10195064A (en) 1997-01-13 1997-01-13 Production of 5-amino-1,2,4-thiadiazoleacetic acid derivative (syn-isomer)

Publications (1)

Publication Number Publication Date
JPH10195064A true JPH10195064A (en) 1998-07-28

Family

ID=11562926

Family Applications (1)

Application Number Title Priority Date Filing Date
JP363497A Pending JPH10195064A (en) 1997-01-13 1997-01-13 Production of 5-amino-1,2,4-thiadiazoleacetic acid derivative (syn-isomer)

Country Status (1)

Country Link
JP (1) JPH10195064A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102093266A (en) * 2011-01-21 2011-06-15 蚌埠丰原医药科技发展有限公司 Method for preparing O-tosyl-2-carbamoyl-2-methoxyl-imido-acetamido-oxime
CN102127034A (en) * 2010-12-29 2011-07-20 蚌埠丰原医药科技发展有限公司 Preparation method of cefozopran side chain acid
WO2018147368A1 (en) * 2017-02-08 2018-08-16 日産化学株式会社 Method for producing geometric isomer of oximino compound
CN111606869A (en) * 2020-06-18 2020-09-01 山西千岫制药有限公司 Protection method for carboxyl of ceftobiprole active thioester intermediate

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127034A (en) * 2010-12-29 2011-07-20 蚌埠丰原医药科技发展有限公司 Preparation method of cefozopran side chain acid
CN102093266A (en) * 2011-01-21 2011-06-15 蚌埠丰原医药科技发展有限公司 Method for preparing O-tosyl-2-carbamoyl-2-methoxyl-imido-acetamido-oxime
WO2018147368A1 (en) * 2017-02-08 2018-08-16 日産化学株式会社 Method for producing geometric isomer of oximino compound
CN109996793A (en) * 2017-02-08 2019-07-09 日产化学株式会社 The manufacturing method of the geometric isomer of oximido compound
US10710977B2 (en) 2017-02-08 2020-07-14 Nissan Chemical Corporation Method for producing geometrical isomer of oximino compound
CN109996793B (en) * 2017-02-08 2022-02-25 日产化学株式会社 Process for producing geometric isomer of oxime compound
CN111606869A (en) * 2020-06-18 2020-09-01 山西千岫制药有限公司 Protection method for carboxyl of ceftobiprole active thioester intermediate

Similar Documents

Publication Publication Date Title
JP5894531B2 (en) Process for producing N-acylbiphenylalanine
US7781598B2 (en) Process for the preparation of substituted indoles
WO2008144980A1 (en) The preparation method and intermediates of capecitabine
KR101098116B1 (en) Improved process for preparing rebamipide
KR20030051895A (en) Process for Producing Anhydride of Aminothiazole Derivative
JP2682705B2 (en) A method for producing a 2,6-dichlorophenylaminobenzeneacetic acid derivative and a diphenylamine derivative.
US20090171084A1 (en) Production method of aminopyrimidine compound
JPH10195064A (en) Production of 5-amino-1,2,4-thiadiazoleacetic acid derivative (syn-isomer)
JP3166125B2 (en) Production method of indole derivatives
JP4323718B2 (en) Method for producing substituted alkylamine or salt thereof
JP2001064282A (en) Imidazoline compound, its intermediate and production thereof and production of azepine compound and its salt
CN112272665A (en) Process for preparing sitagliptin
JPH09301965A (en) Production of 5-amiono-1,2,4-thiadiazole acetic acid derivative
JPH06279414A (en) Preparation of aryl hydantoin
JP4925518B2 (en) Method for producing substituted alkylamine derivative
JP3216673B2 (en) Method for producing 3-hydroxyisoxazole
US20070037854A1 (en) Process for preparing sulfonamide-containing indole compounds
JP2767295B2 (en) Method for producing indole-3-carbonitrile compound
JP4634168B2 (en) Theanine production method
JP4398636B2 (en) Process for producing N- [3- (acylamino) -4-oxo-6-phenoxy-4H-chromen-7-yl] alkylsulfonamide derivatives or salts thereof and intermediates thereof
JP2001302611A (en) Method for producing 5-trifluoromethyldihydrouracil
JPH03115272A (en) Mandelic acid derivative and production thereof
JP2004300101A (en) Method for producing chloropyrimidine derivative
JP2002047263A (en) 2-amino-omege-cyanoalkanoic acid derivative and method of producing the same
JPH11310558A (en) Production of 2-amino-4,5,3&#39;,4&#39;-tetramethoxybenzophenone